×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [5]
Institute of Chi... [2]
Authors
WANG YITAO [2]
KWOK HANG FAI [2]
LEE MING YUEN [1]
WAN JIANBO [1]
LIN LIGEN [1]
Document Type
Journal article [7]
Date Issued
2015 [4]
2014 [1]
2009 [2]
Language
英語English [7]
Source Publication
Bioorganic and M... [1]
Chemistry and Bi... [1]
Journal of Cance... [1]
OncoTargets and ... [1]
Oncology Letters [1]
Oncotargets & Th... [1]
More...
Indexed By
SCIE [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-7 of 7
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Prognostic significance of combining VEGFa, FLT1 and KDR mRNA expressions in lung cancer
Journal article
Zhang, S. D., McCrudden, C. M., Kwok, H. F.. Prognostic significance of combining VEGFa, FLT1 and KDR mRNA expressions in lung cancer[J]. Oncology Letters, 2015, 1893-1901.
Authors:
Zhang, S. D.
;
McCrudden, C. M.
;
Kwok, H. F.
Favorite
|
IF:
2.5
/
2.4
|
Submit date:2022/06/02
VEGFa
FLT1
KDR
prognostic marker
lung cancer cohorts
The significance of combining VEGFa, FLT1 and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab
Journal article
Zhang, S.D., McCrudden, C.M., Meng, C., Lin, Y., Kwok, H. F.. The significance of combining VEGFa, FLT1 and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab[J]. Oncotargets & Therapy, 2015, 835-843.
Authors:
Zhang, S.D.
;
McCrudden, C.M.
;
Meng, C.
;
Lin, Y.
;
Kwok, H. F.
Favorite
|
IF:
2.7
/
3.1
|
Submit date:2022/06/02
Colon cancer
VEGFa
FLT1
KDR
Angiogenesis
Survival
The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab
Journal article
Zhang S.-D., McCrudden C.M., Meng C., Lin Y., Kwok H.F.. The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab[J]. OncoTargets and Therapy, 2015, 8, 835-843.
Authors:
Zhang S.-D.
;
McCrudden C.M.
;
Meng C.
;
Lin Y.
;
Kwok H.F.
Favorite
|
TC[WOS]:
27
TC[Scopus]:
17
|
Submit date:2018/12/19
Angiogenesis
Colon Cancer
Flt1
Kdr
Survival
Vegfa
The prognostic significance of combining VEGFA, FLT1 and KDR mRNA expressions in brain tumors
Journal article
Zhang S.-D., Leung K.L., McCrudden C.M., Kwok H.F.. The prognostic significance of combining VEGFA, FLT1 and KDR mRNA expressions in brain tumors[J]. Journal of Cancer, 2015, 6(9), 812-818.
Authors:
Zhang S.-D.
;
Leung K.L.
;
McCrudden C.M.
;
Kwok H.F.
Favorite
|
TC[WOS]:
20
TC[Scopus]:
20
|
Submit date:2018/12/19
Angiogenesis
Brain Tumor
Flt1
Kdr
Survival
Vegfa
Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors
Journal article
Lin L.-G., Xie H., Wang Y.-T., Ding J., Ye Y.. Chemical constituents from the heartwood of Haematoxylon campechianum as protein tyrosine kinase inhibitors[J]. Chemistry and Biodiversity, 2014, 11(5), 776.
Authors:
Lin L.-G.
;
Xie H.
;
Wang Y.-T.
;
Ding J.
;
Ye Y.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
12
|
Submit date:2018/10/31
Epihematoxylol b
Haematoxylon Campechianum
Hematoxylol b, 10-o-methyl-
Homoisoflavonoids
Kinase Insert Domain Receptor (Kdr)
Protein Tyrosine Kinases (Ptks)
Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2
Journal article
Duncton M.A.J., Piatnitski Chekler E.L., Katoch-Rouse R., Sherman D., Wong W.C., Smith II L.M., Kawakami J.K., Kiselyov A.S., Milligan D.L., Balagtas C., Hadari Y.R., Wang Y., Patel S.N., Rolster R.L., Tonra J.R., Surguladze D., Mitelman S., Kussie P., Bohlen P., Doody J.F.. Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2[J]. Bioorganic and Medicinal Chemistry, 2009, 17(2), 731-740.
Authors:
Duncton M.A.J.
;
Piatnitski Chekler E.L.
;
Katoch-Rouse R.
;
Sherman D.
;
Wong W.C.
; et al.
Favorite
|
TC[WOS]:
38
TC[Scopus]:
38
|
Submit date:2019/01/16
Angiogenesis
Arylphthalazine
Inhibitor
Kdr
Kinase
Phthalazine
Vegfr-2
Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo
Journal article
Si-Jia Hong, Jian-Bo Wan, Yi Zhang, Guang Hu, Hui-Chao Lin, Sai Wang Seto, Yiu-Wa Kwan, Zhi-Xiu Lin, Yi-Tao Wang, Simon Ming-Yuen Lee. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo[J]. Phytotherapy Research, 2009, 23(5), 677.
Authors:
Si-Jia Hong
;
Jian-Bo Wan
;
Yi Zhang
;
Guang Hu
;
Hui-Chao Lin
; et al.
Favorite
|
TC[WOS]:
84
TC[Scopus]:
96
|
Submit date:2018/10/30
Angiogenesis
Kdr/flk-1
Pi3k-akt-enos
Saponin Extract From Panax Notoginseng (Pns)